Targeted Medical Pharma, Inc.

TRGM

US8761401046

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 10:47:54 2023-07-27 am EDT			5-day change	1st Jan Change
0.0001 ^USD	-.--%		-.--%	-.--%

2019	Targeted Medical Pharma, Inc. Announces Resignation of William B. Horne as Chief Financial Officer	CI
2019	Targeted Medical Pharma, Inc. Announces Resignation of David Silver as Chief Medical Officer and Chairman of the Board of Directors	CI

Dr. Thomas Wenkart Joins Targeted Medical Pharma's Board of Directors

March 10, 2014 at 11:59 pm EDT

Targeted Medical Pharma, Inc. announced that Dr. Thomas Wenkart, Chief Executive and Chairman at Macquarie Health Corporation, has joined the company's board of directors.

Latest news about Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc. Announces Resignation of William B. Horne as Chief Financial Officer	19-05-17	CI
Targeted Medical Pharma, Inc. Announces Resignation of David Silver as Chief Medical Officer and Chairman of the Board of Directors	19-01-22	CI
Targeted Medical Pharma, Inc. Announces Executive Changes	17-12-12	CI
Targeted Medical Pharma, Inc. Auditor Raises 'Going Concern' Doubt	16-04-13	CI
Targeted Medical Pharma, Inc. and Amino Nutritionals LLC Announce Release of THERALEVE	16-03-16	CI
Targeted Medical Pharma Finalizes Exclusive Agreement for Distribution in China	16-01-13	CI
Targeted Medical Pharma, Inc. Auditor Raises 'Going Concern' Doubt	15-04-14	CI
Tauriga Sciences, Inc. Expands Agreement with Targeted Medical Pharma, Inc	15-03-04	CI
Targeted Medical Pharma, Inc. Announces Resignation of William E. Shell as Member of the Board	15-03-03	CI
Targeted Medical Pharma, Inc. announced that it has received $1.2 million in funding.	15-02-23	CI
Targeted Medical Pharma, Inc. announced that it expects to receive $1.2 million in funding.	15-02-22	CI
Targeted Medical Pharma Announces Exclusive Product Distribution Agreement with J-Network Inc in Japan	15-02-19	CI
Targeted Medical Pharma, Inc. Announces Resignation of Paul Pelosi Jr as Member of Audit Committee, Compensation Committee and Nominating Committee	15-02-06	CI
Targeted Medical Pharma, Inc. Announces Expiration of Term of Office of Kim Giffoni as Executive Vice President of Foreign Sales and Investor Relations	15-01-08	CI
Targeted Medical Pharma, Inc. Announces Resignation of Dr. Silver as President and Chief Operating Officer	15-01-06	CI
Targeted Medical Pharma, Inc. Reports Earnings Results for the Third Quarter of 2014	14-11-17	CI
Targeted Medical Pharma, Inc. Announces Second Double-Blind Clinical Trial Results	14-09-23	CI
Targeted Medical Pharma, Inc. Announces Earnings Results for Second Quarter and Six Months Ended June 30, 2014	14-08-14	CI
Tauriga Sciences Inc. Signs License Agreement with Targeted Medical Pharma	14-07-16	CI
Targeted Medical Pharma, Inc. Appoints Kerry Weems as Independent Director and Chairman of the Nominating and Governance Committee and Paul Pelosi as Independent Director	14-06-12	CI
Targeted Medical Pharma, Inc. Announces Earnings Results for the First Quarter Ended March 31, 2014	14-05-21	CI
Targeted Medical Pharma Completes Middle East Distribution Agreement	14-04-17	CI
Targeted Medical Pharma, Inc. Reports Earnings Results for the Fourth Quarter and Fiscal Year Ended December 31, 2013	14-03-31	CI
Dr. Thomas Wenkart Joins Targeted Medical Pharma's Board of Directors	14-03-10	CI
Targeted Medical Pharma, Inc. Launches E-Prescribe Platform for Theramine	14-03-04	CI

Chart Targeted Medical Pharma, Inc.

Duration

Period

More charts

Targeted Medical Pharma, Inc. is a medical nutrition company. The Company is engaged in developing amino acid based medical foods and other oral nutrition products for the long-term management of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep, respiratory disorders, allergies and cognitive disorders. It manufactures eight amino acid based medical foods along with the dietary supplements, which include Grotrexa, AppTrim, Hypertensa Advanced and Clearwayz. Its Targeted Cellular Technology is a patented formulation that allows reduced concentrations of amino acids and other ingredients in the milligram range to stimulate the production of neurotransmitters to treat the nutritional deficiencies associated with certain diseases and conditions. The Companyâs medical food brands include Theramine, Trepadone, Percura, GABAdone, Sentra PM, AppTrim-D and Sentra AM.

Sector

Pharmaceuticals

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
TARGETED MEDICAL PHARMA, INC.	-.--%	2.95K
SUN PHARMACEUTICAL INDUSTRIES LTD.	+16.31%	42.32B
OTSUKA HOLDINGS CO., LTD.	+16.11%	21.29B
SANDOZ GROUP AG	+19.33%	15.29B
CIPLA LIMITED	+18.71%	14.36B
ZYDUS LIFESCIENCES LIMITED	+52.78%	12.81B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-12.40%	6.58B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.28%	5.51B

Generic Pharmaceuticals

Targeted Medical Pharma, Inc.

Equities

TRGM

US8761401046

Pharmaceuticals

Dr. Thomas Wenkart Joins Targeted Medical Pharma's Board of Directors

Latest news about Targeted Medical Pharma, Inc.

Chart Targeted Medical Pharma, Inc.

Company Profile

Sector Generic Pharmaceuticals